154 related articles for article (PubMed ID: 14504972)
1. Apolipoprotein E genotype does not influence the progression of multiple sclerosis.
Savettieri G; Andreoli V; Bonavita S; Cittadella R; Caltagirone C; Fazio MC; Girlanda P; Le Pira F; Liguori M; Logroscino G; Lugaresi A; Nocentini U; Reggio A; Salemi G; Serra P; Tedeschi G; Toma L; Trojano M; Valentino P; Quattrone A
J Neurol; 2003 Sep; 250(9):1094-8. PubMed ID: 14504972
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein E genotype does not associate with disease severity measured by Multiple Sclerosis Severity Score.
Guerrero AL; Laherrán E; Gutiérrez F; Martín-Polo J; Iglesias F; Alcázar C; Peralta J; Rostami P
Acta Neurol Scand; 2008 Jan; 117(1):21-5. PubMed ID: 17883422
[TBL] [Abstract][Full Text] [Related]
3. Association of apolipoprotein E genotypes with prognosis in multiple sclerosis.
Tamam Y; Tasdemir N; Yalman M; Tamam B
Eur Rev Med Pharmacol Sci; 2011 Oct; 15(10):1122-30. PubMed ID: 22165672
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein genotype does not influence MS severity, cognition, or brain atrophy.
van der Walt A; Stankovich J; Bahlo M; Taylor BV; van der Mei IA; Foote SJ; Kilpatrick TJ; Rubio JP; Butzkueven H
Neurology; 2009 Sep; 73(13):1018-25. PubMed ID: 19786693
[TBL] [Abstract][Full Text] [Related]
5. [The absence of a relation between apolipoprotein E genotypes and the severity of multiple sclerosis in Mexican patients].
Corona T; Guerrero-Camacho JL; Alonso-Vilatela ME; Flores-Rivera Jde J
Rev Neurol; 2010 Jan 1-15; 50(1):19-22. PubMed ID: 20073019
[TBL] [Abstract][Full Text] [Related]
6. [Apolipoprotein E polymorphism as a predictor of progression of multiple sclerosis].
Guerrero AL; Bueno V; Hernández MT; Martín-Serradilla JI; Carrasco E; Cuadrado I
Neurologia; 2003 Apr; 18(3):146-8. PubMed ID: 12677480
[TBL] [Abstract][Full Text] [Related]
7. Influence of apolipoprotein E epsilon4 genotype on brain tissue integrity in relapsing-remitting multiple sclerosis.
De Stefano N; Bartolozzi ML; Nacmias B; Zipoli V; Mortilla M; Guidi L; Siracusa G; Sorbi S; Federico A; Amato MP
Arch Neurol; 2004 Apr; 61(4):536-40. PubMed ID: 15096402
[TBL] [Abstract][Full Text] [Related]
8. The relationship of APOE genetic polymorphism with susceptibility to multiple sclerosis and its clinical phenotypes in Kuwaiti Arab subjects.
Al-Shammri S; Fatania H; Al-Radwan R; Akanji AO
Clin Chim Acta; 2005 Jan; 351(1-2):203-7. PubMed ID: 15563891
[TBL] [Abstract][Full Text] [Related]
9. APOE epsilon variation in multiple sclerosis susceptibility and disease severity: some answers.
Burwick RM; Ramsay PP; Haines JL; Hauser SL; Oksenberg JR; Pericak-Vance MA; Schmidt S; Compston A; Sawcer S; Cittadella R; Savettieri G; Quattrone A; Polman CH; Uitdehaag BM; Zwemmer JN; Hawkins CP; Ollier WE; Weatherby S; Enzinger C; Fazekas F; Schmidt H; Schmidt R; Hillert J; Masterman T; Hogh P; Niino M; Kikuchi S; Maciel P; Santos M; Rio ME; Kwiecinski H; Zakrzewska-Pniewska B; Evangelou N; Palace J; Barcellos LF
Neurology; 2006 May; 66(9):1373-83. PubMed ID: 16682670
[TBL] [Abstract][Full Text] [Related]
10. ApolipoproteinE epsilon 4 allele is not associated with disease course and severity in multiple sclerosis.
Portaccio E; Zipoli V; Goretti B; Hakiki B; Nacmias B; Siracusa G; Sorbi S; Amato MP
Acta Neurol Scand; 2009 Dec; 120(6):439-41. PubMed ID: 19804477
[TBL] [Abstract][Full Text] [Related]
11. No effect of APOE and PVRL2 on the clinical outcome of multiple sclerosis.
Ramagopalan SV; Deluca GC; Morrison KM; Herrera BM; Dyment DA; Orton S; Bihoreau MT; Degenhardt A; Pugliatti M; Sadovnick AD; Sotgiu S; Ebers GC
J Neuroimmunol; 2007 May; 186(1-2):156-60. PubMed ID: 17376543
[TBL] [Abstract][Full Text] [Related]
12. Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran.
Raygani AV; Zahrai M; Raygani AV; Doosti M; Javadi E; Rezaei M; Pourmotabbed T
Neurosci Lett; 2005 Feb; 375(1):1-6. PubMed ID: 15664112
[TBL] [Abstract][Full Text] [Related]
13. The impact of our genes: consequences of the apolipoprotein E polymorphism in Alzheimer disease and multiple sclerosis.
Fazekas F; Enzinger C; Ropele S; Schmidt H; Schmidt R; Strasser-Fuchs S
J Neurol Sci; 2006 Jun; 245(1-2):35-9. PubMed ID: 16631796
[TBL] [Abstract][Full Text] [Related]
14. The apolipoprotein E gene polymorphism is associated with open angle glaucoma in the Japanese population.
Mabuchi F; Tang S; Ando D; Yamakita M; Wang J; Kashiwagi K; Yamagata Z; Iijima H; Tsukahara S
Mol Vis; 2005 Aug; 11():609-12. PubMed ID: 16110302
[TBL] [Abstract][Full Text] [Related]
15. Increased risk of late posttraumatic seizures associated with inheritance of APOE epsilon4 allele.
Diaz-Arrastia R; Gong Y; Fair S; Scott KD; Garcia MC; Carlile MC; Agostini MA; Van Ness PC
Arch Neurol; 2003 Jun; 60(6):818-22. PubMed ID: 12810485
[TBL] [Abstract][Full Text] [Related]
16. Osteopontin polymorphisms and disease course in multiple sclerosis.
Caillier S; Barcellos LF; Baranzini SE; Swerdlin A; Lincoln RR; Steinman L; Martin E; Haines JL; Pericak-Vance M; Hauser SL; Oksenberg JR;
Genes Immun; 2003 Jun; 4(4):312-5. PubMed ID: 12761568
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein E polymorphisms status in Iranian patients with multiple sclerosis.
Rafiei M; Zarif Yeganeh M; Sheikholeslami S; Gozalpour E; Ghaffarpour M; Hedayati M
J Neurol Sci; 2012 Sep; 320(1-2):22-5. PubMed ID: 22698480
[TBL] [Abstract][Full Text] [Related]
18. Apo E in multiple sclerosis and optic neuritis: the apo E-epsilon4 allele is associated with progression of multiple sclerosis.
Pinholt M; Frederiksen JL; Andersen PS; Christiansen M
Mult Scler; 2005 Oct; 11(5):511-5. PubMed ID: 16193886
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein E polymorphism and central nervous system tumors: correlation with cell proliferation indices and clinical outcome.
Zunarelli E; Nicoll JA; Trentini GP
Clin Neuropathol; 2000; 19(1):1-6. PubMed ID: 10774944
[TBL] [Abstract][Full Text] [Related]
20. Presence of apolipoprotein E epsilon4 allele predisposes to early onset of primary Sjogren's syndrome.
Pertovaara M; Lehtimäki T; Rontu R; Antonen J; Pasternack A; Hurme M
Rheumatology (Oxford); 2004 Dec; 43(12):1484-7. PubMed ID: 15328426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
